欧洲起搏器市场到 2027 年 - 按产品类型(植入式起搏器、体外起搏器)、按技术(单腔、双腔和双心室)、最终用户(医院、门诊手术中心等)进行的区域分析和预测,以及国家

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 126    |    Report Code: TIPRE00006296    |    Category: Life Sciences

Europe Pacemakers Market

欧洲起搏器市场预计将从 2018 年的 12.487 亿美元增至 2027 年的 24.085 亿美元。预计 2019-2027 年该市场的复合年增长率为 7.7%。

 

欧洲经济增长的特点是心血管疾病患病率上升、欧洲技术进步迅速,以及不断增长的医疗保健市场。

 

心血管疾病与饮食习惯、运动和吸烟等因素有关。基因组成也与心血管疾病有关。低出生体重与冠心病、中风和高血压有关。肥胖者患心血管疾病的风险较高,因为肥胖与高血压和低浓度的高密度脂蛋白胆固醇有关。根据 2017 年欧洲心血管疾病统计数据,欧洲有 390 万人死于心血管疾病。此外,它还提到,心血管疾病占欧洲所有死亡人数的45%,占欧盟所有死亡人数的37%。此外,根据《烟草和口腔健康情况说明书》(2018 年),欧洲成年人吸烟率最高(28%)。还提到,世界卫生组织欧洲区域是因烟草使用死亡人数较多的区域之一。因此,欧洲心血管疾病的高患病率预计将引领未来几年的市场增长。

 

此外,2016年至2019年期间,各公司在其运营的市场上制定了有机和无机增长战略。该公司开展的一些促进其发展的活动包括产品发布、收购和合作。有机发展战略的广泛实施,促进了企业的成长,也带来了市场的各种变化。例如,2017 年 6 月,百多力推出了采用百多力 MRI AutoDetect 技术的起搏器系列。具有 MRI AutoDetect 功能的 Edora 系列最大限度地减少了编程负担,确保 MR 成像过程中患者的安全。

 

法国起搏器预计市场在预测期内将以最高速度增长。该市场的增长主要是由心血管疾病患病率的增加、起搏器植入数量的增加、电子植入设备的不断出现以及新型心律管理解决方案的推出推动的。

 

 

< strong>欧洲起搏器市场——市场细分

 

欧洲起搏器市场 -按

产品

类型

  • 植入式起搏器
  • 外部起搏器

欧洲起搏器市场 -按技术

  • 单室
  • 双室
  •  双心室

欧洲起搏器市场 -由

最终用户

  • 医院和医院诊所
  • 门诊手术中心
  • 家庭护理

 

按地理位置

•  欧洲

  • 英国
  • 德国
  • 法国
  • 意大利
  • 西班牙
  •  

    公司简介

    • 美敦力
    • 雅培
    • 百多力
    • LivaNova Plc
    • < li>波士顿科学公司
    • 乐普医疗
    • MEDICO SpA
    • Vitatron Holding BV
    • OSCOR Inc
    • Pacetronix


    Europe Pacemakers Strategic Insights

    Strategic insights for Europe Pacemakers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-pacemakers-market-strategic-framework.webp
    Get more information on this report

    Europe Pacemakers Report Scope

    Report Attribute Details
    Market size in 2018 US$ 1,248.7 Million
    Market Size by 2027 US$ 2,408.5 Million
    Global CAGR (2019 - 2027) 7.7%
    Historical Data 2016-2017
    Forecast period 2019-2027
    Segments Covered By 产品类型
    • 植入式起搏器
    • 体外起搏器
    By 技术
    • 单腔
    • 双腔
    • 双心室
    By 最终用户
    • 医院
    • 门诊手术中心
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • Medtronic
  • Abbott
  • BIOTRONIK
  • LivaNova Plc.
  • Boston Scientific Corporation
  • Lepu Medical
  • MEDICO S.p.A.
  • Vitatron Holding B.V.
  • OSCOR Inc
  • Pacetronix
  • Get more information on this report

    Europe Pacemakers Regional Insights

    The regional scope of Europe Pacemakers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-pacemakers-market-geography.webp
    Get more information on this report

The List of Companies - Europe Pacemakers Market

The List of Companies

 

  1. Medtronic
  2. Abbott
  3. BIOTRONIK
  4. LivaNova Plc.
  5. Boston Scientific Corporation
  6. Lepu Medical
  7. MEDICO S.p.A.
  8. Vitatron Holding B.V.
  9. OSCOR Inc
  10. Pacetronix

 

Frequently Asked Questions
How big is the Europe Pacemakers Market?

The Europe Pacemakers Market is valued at US$ 1,248.7 Million in 2018, it is projected to reach US$ 2,408.5 Million by 2027.

What is the CAGR for Europe Pacemakers Market by (2019 - 2027)?

As per our report Europe Pacemakers Market, the market size is valued at US$ 1,248.7 Million in 2018, projecting it to reach US$ 2,408.5 Million by 2027. This translates to a CAGR of approximately 7.7% during the forecast period.

What segments are covered in this report?

The Europe Pacemakers Market report typically cover these key segments-

  • 产品类型 (植入式起搏器, 体外起搏器)
  • 技术 (单腔, 双腔, 双心室)
  • 最终用户 (医院, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Europe Pacemakers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pacemakers Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Europe Pacemakers Market?

    The Europe Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic
  • Abbott
  • BIOTRONIK
  • LivaNova Plc.
  • Boston Scientific Corporation
  • Lepu Medical
  • MEDICO S.p.A.
  • Vitatron Holding B.V.
  • OSCOR Inc
  • Pacetronix
  • Who should buy this report?

    The Europe Pacemakers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.